Chemed Corporation (CHE)
NYSE: CHE · Real-Time Price · USD
421.10
-1.62 (-0.38%)
At close: Apr 28, 2026, 4:00 PM EDT
421.10
0.00 (0.00%)
After-hours: Apr 28, 2026, 7:00 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
VITAS Revenue
1.64B1.63B1.53B
VITAS Revenue Growth
0.77%6.47%16.42%
Roto-Rooter Revenue
897.83M899.88M900.31M
Roto-Rooter Revenue Growth
-0.23%-0.05%-5.17%
Revenue (Other)
2.00K3.00K1,000.00
Revenue (Total)
2.54B2.53B2.43B
Revenue (Total) Growth
0.42%4.06%7.37%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
VITAS Income From Operations
246.62M246.94M263.97M
VITAS Income From Operations Growth
-0.13%-6.45%43.39%
Roto-Rooter Income From Operations
154.84M160.83M194.52M
Roto-Rooter Income From Operations Growth
-3.72%-17.32%-14.22%
Corporate Income From Operations
-73.40M-69.52M-91.99M
Operating Income (Total)
328.07M338.25M366.49M
Operating Income (Total) Growth
-3.01%-7.71%7.61%

Adjusted EBITDA

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
VITAS Adjusted EBITDA
272.31M271.91M285.54M
VITAS Adjusted EBITDA Growth
0.15%-4.77%39.70%
Roto-Rooter Adjusted EBITDA
199.05M204.73M237.09M
Roto-Rooter Adjusted EBITDA Growth
-2.77%-13.65%-12.05%
Corporate Adjusted EBITDA
-18.09M-17.93M-19.62M
Operating Income (Other)
-125.21M-120.46M-136.51M
Operating Income (Total)
328.07M338.25M366.49M
Operating Income (Total) Growth
-3.01%-7.71%7.61%

Net Income

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
VITAS Net Income
206.19M204.01M216.82M
VITAS Net Income Growth
1.07%-5.91%36.79%
Roto-Rooter Net Income
131.33M135.49M160.05M
Roto-Rooter Net Income Growth
-3.07%-15.34%-14.98%
Corporate Net Income
-77.74M-74.26M-74.87M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Total Average Daily Census (ADC) (Days)
-22.34K21.17K
Total Average Daily Census (ADC) (Days) Growth
-5.51%13.74%
Total Admissions
72.07K70.82K67.45K
Total Admissions Growth
1.77%5.00%6.33%
Total Discharges
71.33K70.53K64.62K
Total Discharges Growth
1.13%9.15%5.51%
Average Length of Stay (Days)
-120.20103.00
Average Length of Stay (Days) Growth
-16.70%0.78%
Median Length of Stay (Days)
-18.0017.00
Median Length of Stay (Days) Growth
-5.88%6.25%
Updated Apr 23, 2026. Data Source: Fiscal.ai.